Related Experiment Video
Updated: Jul 7, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
A Rare Case of Arterial and Venous Thrombosis in COVID-19
Shekhar Bhatta1, Elina Shrestha2, Asmita Sigdel3
1Internal Medicine, BronxCare Health System, Bronx, USA.
Insights
This case study details a rare instance of extensive thrombosis, including deep vein thrombosis, pulmonary embolism, and aortic thrombus, in a COVID-19 patient. It underscores the critical need for vigilant monitoring and management of thrombotic risks in individuals with coronavirus disease 2019.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Hematology
Background:
- The COVID-19 pandemic has revealed a heightened risk of thrombotic events in infected patients.
- Understanding the prothrombotic mechanisms in COVID-19 is crucial for patient management.
Observation:
- A 64-year-old male with COVID-19 presented with respiratory failure requiring ICU admission.
- The patient developed bilateral deep vein thrombosis (DVT), pulmonary embolism (PE), and aortic thrombus (thoracic and abdominal).
Findings:
- COVID-19 infection was associated with widespread venous and arterial thrombosis in this rare case.
- Prompt anticoagulation and vascular surgery consultation were initiated for management.
Implications:
- This case emphasizes the critical importance of recognizing and managing thrombotic complications in COVID-19.
- A multi-modal approach is necessary to address the prothrombotic state induced by COVID-19.
- Further research is needed to refine treatment protocols for COVID-19-associated thrombosis.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has brought attention to the significant risk of thrombotic complications in infected individuals. We present a rare case of a 64-year-old male with COVID-19 who developed bilateral deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombus in the thoracic and abdominal aorta. The patient exhibited common symptoms of COVID-19 and required intensive care unit admission due to respiratory failure. Subsequent investigations revealed thrombi in the lower extremities, pulmonary arteries, and aorta. Prompt anticoagulation therapy was initiated, and vascular surgery consultation was sought. This case highlights the increased risk of venous and arterial thrombotic events in COVID-19 patients and emphasizes the importance of comprehensive management strategies. The interplay of various factors in COVID-19 contributes to a prothrombotic state, necessitating a multi-modal approach to address thrombotic complications. Further research is needed to optimize treatment protocols and improve outcomes for COVID-19 patients with thrombotic complications.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Veins of Upper Limbs
The deep venous system is primarily composed of the ulnar and radial veins. The ulnar vein, which drains the fingers through the superficial palmar venous arches, and the radial vein, which serves the palms via the deep palmar...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Vascular Spasm

